PIROUETTE MEDICAL

Medtech · Private

Auto-injector device for naloxone administration

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$479K
Federal grants
$479K
3 awards · 2023–2024
Rank in peer group#240 of 445
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
5 pending · first 2019
Rank in peer group#36 of 445

Capital timeline

20232024FEDERAL ↑EQUITY ↓Cumulative $479K$327K$55K$98K
20232024FEDERAL ↑EQUITY ↓Cumulative $479K$327K$55K$98K

Latest events

  • Federal grantHealth and Human S · Phase I · A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$98K
  • Federal grantHealth and Human S · Phase I · A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$55K
  • Federal grantHealth and Human S · Phase I · A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose$327K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#36 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • ELIJAH KAPASResearcherExecutive Officer, Director, PromoterLinked by 6 patents
  • CONOR CULLINANEResearcherExecutive Officer, Director, PromoterLinked by $479K in grants as PI
  • ARUNAS CHESONISExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • JOSEPH NEMMERSExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • MATTHEW KANEExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 11
Show all 11 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .